MDS-AOS: 1st Virtual MDS Botulinum toxin Conference 2020

Lectures and associated resources available November 13, 2020
Live Q&A session November 21, 2020 12:00 GMT/16:00 Gulf Standard Time

 

Register

Course Director

Shivam Om Mittal, MD
Sabahat Wasti, MD

Faculty

Cynthia  Comella, MD, FAAN, FASM, FANA
Joseph Jankovic, MD
Eduardo Francisco Cardoso, MD, PhD, FAAN
Raymond Rosales, MD, PhD
Wolfgang H. Jost, MD, PhD

Course Description

Botulinum Neurotoxin (BoNT) has increasing number of therapeutic indications in neurological practice especially movement disorders. There is a clear need for a comprehensive training of BoNT injection by understanding the history, pharmacology, indications, techniques and potential pitfalls if toxin injections are performed sub-optimally. This four-hour online activity is for neurologists, general physicians and movement disorder enthusiasts to listen to comprehensive insight to the implications of BoNT in movement disorders. 

Lectures will be available for on-demand viewing starting on Friday, November 13, 2020.

Interactive Components

Join the faculty for a live Question and Answer session on Saturday, November 21 at 12:00-12:30 GMT (16:00 Gulf Standard Time).

Target Audience

General neurologists, Movement disorder neurologists, Physical Medicine and Rehabilitation specialists, General physicians, geriatricians

Learning Objectives 
  1. To learn about the basics of botulinum toxin and its pharmacology
  2. Master class by the world experts on botulinum toxin in several movement disorders
  3. To identify movement disorders that can be treated with botulinum toxin injections
     
Agenda

Lecture Title

Faculty Member

Duration of Lecture

Introduction and course overview

Dr. Shivam Om Mittal

5 minutes

Session 1: Botulinum toxin in Cranio-Cervical Conditions

Chairpersons: Course Directors

Techniques for BoNT injection-EMG vs US vs Palpation

Dr. Wolfgang H. Jost

30 minutes

Understanding Cervical Dystonia and treatment with BoNT

Dr.  Cynthia Comella

30 minutes

BoNT in Cranial Dystonia- Blepharospasm, Hemifacial spasm, Oromandibular and laryngeal dystonia

Dr. Eduardo F Cardoso

 

30 minutes

Session 2: Botulinum toxin in Appendicular Conditions

Chairpersons: Course Directors

BoNT in treatment of Focal Hand dystonia

Dr. Joseph Jankovic

30 minutes

BoNT in the treatment of Spasticity

Dr Sabahat Wasti

30 minutes

BoNT in the treatment of Tremor conditions

Dr. Shivam Om Mittal

30 minutes

Immunogenicity and advances in BoNT treatment

Dr. Raymond Rosales

30 minutes

 
Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The International Parkinson and Movement Disorder Society designates this activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation.

Satisfactory Completion:

Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.

Content Validity Statement:

All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.

Disclosure of Financial Relationships:

All individuals in control of content for this webinar are required to disclose all relevant financial relationships with commercial interests as defined by the ACCME. 

Top

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice